D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer

  • Authors:
    • Hong Dai
    • Hongxing Zhou
    • Yingxin Sun
    • Zhe Xu
    • Shuo Wang
    • Tongbao Feng
    • Ping Zhang
  • View Affiliations

  • Published online on: September 14, 2018     https://doi.org/10.3892/br.2018.1151
  • Pages: 453-457
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

D‑dimer is a widely used biomarker for indicating the activation of coagulation and fibrinolysis, and is reported to serve important roles in cancer progression. The aim of the current retrospective study was to investigate the association of D‑dimer plasma level with the development of various cancers. Patients with breast (n=86), gastric (n=317), pancreatic (n=37), colon (n=153) and rectal (n=137) cancers and 92 healthy volunteers were assessed in the present study. Plasma levels of D‑dimer in the patients and healthy controls were measured by immunoturbidimetric assays. The association of D‑dimer levels with the clinicopathological features of patients were also determined. The plasma levels of D‑dimer were significantly higher in patients with breast cancer (P=0.0022), gastric cancer (P<0.0001), pancreatic cancer (P=0.0003), colon cancer (P=0.0001) and rectal cancer (P=0.0028), compared with the healthy controls. It was also determined that the plasma D‑dimer levels were positively associated with clinical cancer stage (P<0.05) and metastasis (P<0.05). These findings suggested that the plasma D‑dimer level may be used as marker for predicting cancer metastasis and progression.

References

1 

Jiang X, Mei X, Wu H and Chen X: D-dimer level is related to the prognosis of patients with small cell lung cancer. Ann Transl Med. 5:3942017. View Article : Google Scholar : PubMed/NCBI

2 

Kobayashi T, Kajiki M, Nihashi K and Honda G: Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation. Thromb Res. 159:109–115. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Ahmed S, Siddiqui AK, Iqbal U, Sison CP, Shahid RK, Sheth M, Patel DV and Russo LA: Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: A brief report. Eur J Haematol. 72:213–216. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AG and Mannucci PM: Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost. 81:879–886. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Kwietniak M, Al-Amawi T, Błaszkowski T, Sulżyc-Bielicka V and Kładny J: The usefulness of D-dimer in diagnosis and prediction of venous thromboembolism in patients with abdominal malignancy. Pol Przegl Chir. 89:27–30. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Zhang H, Qiu B, Zhang Y, Cao Y, Zhang X, Wu Z, Wang S and Mei L: The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients. Med Sci Monit. 24:4528–4535. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, et al: Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood. 118:2889–2895. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA and Muschel RJ: Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64:8613–8619. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Huang W and Kim HR: Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis. J Biol Chem. 290:9162–9170. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Hamzah AB, Choo YM, Hassali MA, Saleem F and Verma AK: Disseminated Intravascular Coagulation and Excessive Fibrinolysis (DIC XFL) Syndrome in Prostate Cancer: A Rare Complicated Disorder. J Clin Diagn Res. 11:XD01–XD02. 2017.PubMed/NCBI

11 

Hong SK, Ko DW, Park J, Kim IS, Doo SH, Yoon CY, Park H, Lee WK, Kim DS, Jeong SJ, et al: Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer. Korean J Urol. 51:25–29. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Khoury JD, Adcock DM, Chan F, Symanowski JT, Tiefenbacher S, Goodman O, Paz L, Ma Y, Ward DC, Vogelzang NJ, et al: Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. Am J Clin Pathol. 134:964–969. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Luo YL, Chi PD, Zheng X, Zhang L, Wang XP and Chen H: Preoperative D-dimers as an independent prognostic marker in cervical carcinoma. Tumour Biol. 36:8903–8911. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M, Minaguchi T, Sakurai H, et al: Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb Res. 131:e127–e132. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Sun YH, Cui L, Chen J, Wang M, Liu JJ, Liu XX and Huang XE: Analysis of Relationships Between Prethrombotic States and Cervical Cancer. Asian Pac J Cancer Prev. 16:6163–6166. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Feng JF, Yang X, Chen S, Zhao Q and Chen QX: Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China. J Cancer. 7:1663–1667. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, et al: National Comprehensive Cancer Network: Invasive breast cancer. J Natl Compr Canc Netw. 9:136–222. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, et al: National Comprehensive Cancer Network: Thymic malignancies. J Natl Compr Canc Netw. 8:1302–1315. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Romanus D, Weiser MR, Skibber JM, Ter Veer A, Niland JC, Wilson JL, Rajput A, Wong YN, Benson AB III, Shibata S, et al: Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: An NCCN institutional analysis. J Natl Compr Canc Netw. 7:895–904. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Benson AB III, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, et al: National Comprehensive Cancer Network: Colon cancer. J Natl Compr Canc Netw. 9:1238–1290. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Engstrom PF, Arnoletti JP, Benson AB III, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, et al: National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Rectal cancer. J Natl Compr Canc Netw. 7:838–881. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Ma J and Qiu LG: Guidelines for treatment of myeloma bone disease. Zhonghua Xue Ye Xue Za Zhi. 32:721–723. 2011.(In Chinese). PubMed/NCBI

23 

Lymphoma Working Party of Chinese Society of Hematology, . Chinese guidelines for the diagnosis and management of chronic lymphocytic leukemia. Zhonghua Xue Ye Xue Za Zhi. 32:498–501. 2011.(In Chinese). PubMed/NCBI

24 

Shen ZX; Chinese Society of Hematology, ; Chinese Medical Association, : Chinese guidelines for the diagnosis and treatment of acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi. 32:885–886. 2011.(In Chinese). PubMed/NCBI

25 

Shi A, Huang J, Wang X, Li M, Zhang J, Chen Y and Huang Y: Postoperative D dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery. Urol Oncol. 36:307 e315 307 e3212018. View Article : Google Scholar

26 

Yao Y, Shen H, Zhou Y, Yang Z and Huang H: Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimer. Oncol Lett. 15:4397–4403. 2018.PubMed/NCBI

27 

Zhang B, Liu G, Liu X, Zheng S, Dong K and Dong R: Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients. Medicine (Baltimore). 96:e87982017. View Article : Google Scholar : PubMed/NCBI

28 

Pace A, Mandoj C, Antenucci A, Villani V, Sperduti I, Casini B, Carosi M, Fabi A, Vidiri A, Koudriavtseva T, et al: A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma. J Neurooncol. 138:527–535. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Khangarot SS, Gupta N, Goswami B, Hadke NS, Lal P, Gupta N and Khurana N: Correlation of D dimer and factor VIII levels with histopathology in patients with breast carcinoma. Cancer Biomark. 7:305–314. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, Key NS, Barcel DA, Scheithauer W, Kornek G, et al: Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost. 10:1363–1370. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M and Degen JL: Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 105:178–185. 2005. View Article : Google Scholar : PubMed/NCBI

32 

Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL and Bugge TH: Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 96:3302–3309. 2000.PubMed/NCBI

33 

Batschauer AP, Figueiredo CP, Bueno EC, Ribeiro MA, Dusse LM, Fernandes AP, Gomes KB and Carvalho MG: D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Ann Oncol. 21:1267–1272. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M and Greenberg C: Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 18:600–608. 2000. View Article : Google Scholar : PubMed/NCBI

35 

Cui LN, Li N, Fu S, Zhang X, Wang X and Wang RT: Combination of preoperative D-dimer and mean platelet volume predicts postoperative deep venous thrombosis in breast cancer patients. Cancer Biomark. 21:909–913. 2018. View Article : Google Scholar : PubMed/NCBI

36 

Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, et al: Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thromb Haemost. 113:593–598. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Diao D, Cheng Y, Song Y, Zhang H, Zhou Z and Dang C: D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer. 17:562017. View Article : Google Scholar : PubMed/NCBI

38 

Lee S, Huh SJ, Oh SY, Koh MS, Kim SH, Lee JH, Han JY, Choi HJ, Kim SJ and Kim HJ: Clinical significance of coagulation factors in operable colorectal cancer. Oncol Lett. 13:4669–4674. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Stender MT, Larsen TB, Lundbye-Christensen S, Yilmaz MK and Thorlacius-Ussing O: Haemostatis activity in rectal cancer patients exposed to preoperative radiotherapy: A clinical prospective cohort study. Blood Coagul Fibrinolysis. 20:276–282. 2009. View Article : Google Scholar : PubMed/NCBI

40 

Durczynski A, Skulimowski A, Hogendorf P, Szymanski D, Kumor A, Marski K, Juliebø SØ, Poznanska G and Strzelczyk J: The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer. World J Surg Oncol. 15:2232017. View Article : Google Scholar : PubMed/NCBI

41 

Cao J, Fu Z, Gao L, Wang X, Cheng S, Wang X and Ren H: Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma. World J Surg Oncol. 15:482017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

November 2018
Volume 9 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., & Zhang, P. (2018). D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomedical Reports, 9, 453-457. https://doi.org/10.3892/br.2018.1151
MLA
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., Zhang, P."D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer". Biomedical Reports 9.5 (2018): 453-457.
Chicago
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., Zhang, P."D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer". Biomedical Reports 9, no. 5 (2018): 453-457. https://doi.org/10.3892/br.2018.1151